Search Results

Your search matched 63 results

#1

IBM Watson for Oncology | Blog

Originally built as a complement for a physician and not as a replacement, IBM Watson for Oncology launched a study to determine how closely the artificial intelligence computer and a panel of 12-15 multidisciplinary tumor board members could agree on treatment approaches.

#2

Immuno-oncology is fundamentally changing what value means | In The Media

How will the pharma marketing, educational and service model adapt in response to redefined value in immuno-oncology?

#3

Making the Most of Maturing Oncology Brands | In The Media

Our experts crafted a checklist for Pharmaceutical Executive that can be used to determine if there’s hidden vitality left in aging oncology brands and inspire outside-of-the-box, often low-investment solutions to grow the bottom line.

#4

The Social Oncology Report: ASCO and Beyond | Blog

MDigitalLife (a division of the W20 Group) recently conducted an examination of specific cancer communities online.

#5

Clearing a Commercial Path for Novel Cancer Therapeutics in a Post-Pandemic World | Perspectives

Part I of a Syneos Health Series on New Oncology Commercialization Strategies

#6

Navicor | Agency

Full-service, oncology-focused advertising agency transforming products into brands and patients into survivors.

#7

Betting Big on Cancer.com | Blog

This month, Janssen launched Cancer.com, aiming to create an online destination for all things oncology.

#8

GSW and Biosector 2 Are Shortlisted for 2019 MM&M Awards | In The Media

GSW and Biosector 2 are shortlisted for 2019 MM&M Awards for our client work with Endo Pharmaceuticals and Novartis Oncology.

#9

Growing Number of Cancer Patients are Finding Limited Access to Care | Blog

In 2014, the American Society of Clinical Oncology (ASCO) released a landmark report about the state of cancer care in America.

#10

New drugs, new money: Surge in cancer DTC ads follows wave of I-O debuts | In The Media

There's been a spike in oncology DTC advertising in recent years, thanks to new drugs and mechanisms of action – and Syneos Health™ has the research to prove it.

#11

PATIENT PARTNERS IN ONCOLOGY | Perspectives

Noticing important shifts in the rules of engagement between industry and patient advocates, Syneos Health Public Relations Group conducted in-depth interviews with dozens of patient organizations in early 2015.

#12

Future look: The Impact of Biosimilars on Oncology | In The Media

Ben Curtis and Katherine Seay, inVentiv Health Managed Markets comment on how strategies will adjust with the advent of biosimilars.

#13

Creating a Culture of Measurement | Blog

David Lennon, VP & Franchise Head for US Oncology at Novartis, showed the #efpphilly crowd where we’re at as an industry with technology and data and where our opportunities lie for greater collaboration.

#15

Using LinkedIn for micro-targeting oncologists | Blog

During this year’s Digital Pharma East conference, Stephanie Katzman, a healthcare strategist at LinkedIn, announced that the number of HCPs had grown from 3.5 million last year to over 5 million in the US alone and over 9 million globally in 2015.

#16

CANCERCON : Because Young Adult Cancer Sucks | Blog

CANCERCON is the experience that you never knew you needed because who the hell thinks about cancer when you’re not eighty years old?

#17

eyeforpharma Barcelona 2020: Insight Driven Patient-Centricity | Blog

Interested in how life science companies are approaching patient-centricity at eyeforpharma Barcelona 2020?

#18

Inspiration in Pfizer's This Is Living With Cancer | Blog

Live from Cannes Lions: 9 people living with cancer + 6 months in their homes and lives = a story that shows it is possible to find a new normal

#19

A new approach to fighting drug shortages | Blog

Shortages of critical cancer-fighting drugs have impacted 83% of U.S. oncologists in the past six months.* Around the world, doctors are negotiating availability, access and funding for the infusions they most want to prescribe.

#20

The Right Care in the Right Place at the Right Time | Blog

A daunting task for any doctor.

#21

Vision 2020: Warm culture means healthy growth | Blog

It’s been mighty cold lately, hasn’t it?

#22

Tune in Doc-Virtual Conferences Are Now a Reality | Blog

2017 has marked a major shift in the way pharmaceutical giant Novartis will be using and expanding innovative digital platforms to share major congress experiences, education and medical information with physicians.

#23

‘Value’: A Baker’s Dozen Fresh Quotes from Today’s Industry Execs | Blog

Live from EFP ‘18: The closing session for eyeforpharma ’18 brought the story full circle.

#24

GSK Gains Targeted Therapy, Footing in Boston with $5.1-billion Tesaro Buy | Blog

GlaxoSmithKline announced that it will acquire Waltham, Massachusetts-based drug company Tesaro, which develops novel cancer treatments, for $5.1 billion cash.

#25

The Rise of Alternative Therapies and Their Potential to Impact Cancer Treatment | Blog

Complementary and alternative medicines (CAM) are therapies that are not considered the standard of care for a medical condition, and they represent $30 billion per year in consumer spending.

#26

Oncologists Should Be Asking Patients, ‘Do You Even Lift?’ | Blog

A global alliance of 17 organizations, headed up by the American College of Sports Medicine (ACSM), published a report advising doctors to prescribe exercise to cancer patients.

#27

Wellness in the Workplace Turns to Genomic Testing | Blog

With healthcare expenses always seemingly on the rise, if you had the opportunity to reduce healthcare costs in your company by $1,464 annually per employee would you?

#28

Smart Socks Predict Foot Ulcers in Diabetic Patients | Blog

Wearables have been all the rage over the past few years.

#29

Utah sends patients south for drugs & value-based contracts could sail into safe harbor | Blog

Well, readers, it is - - amazingly - - the last month of 2018.

#30

The Week That Was: Crises in Communications | Blog

No matter whether you were the lone staffer in your office or relaxing on a beach somewhere this past week, we’ve got the run down on the latest healthcare headlines—the good, the bad and the ugly—to help you get you back up to speed.